Quoin Pharmaceuticals Stock (NASDAQ: QNRX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 50.70K |
Day Range | - - - |
52 Wk Range | 0.57 - 12.00 |
Market Cap | $2.49M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 0.32% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Quoin Pharmaceuticals (NASDAQ:QNRX) through any online brokerage.
Other companies in Quoin Pharmaceuticals’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Bone Biologics (NASDAQ:BBLG).
There is no analysis for Quoin Pharmaceuticals.
Quoin Pharmaceuticals has a consensus price target of $8.50.
The stock price for Quoin Pharmaceuticals (NASDAQ: QNRX) is $0.6246 last updated July 19, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Quoin Pharmaceuticals.
Quoin Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Quoin Pharmaceuticals.
Quoin Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.